Here, we shed light on the importance of the immunoproteasome and p38 MAPK in IFNγ-mediated and drug-induced resistance of CLL cells to venetoclax, and the potential of targeting the immunoproteasome and p38 MAPK to successfully overcome this resistance. This evidence concerns the gene IFNG and B-cell chronic lymphocytic leukemia.